Pharmaceutical Online Videos
-
Complementary Methodologies For Size Heterogeneity Analysis Of Antibody Impurities
6/22/2026
Combining denaturing and native analytical techniques reveals molecular weight impurities in mAbs, delivering a more complete and reliable purity profile that supports confident decisions.
-
Samsung Biologics Capabilities Update June 2026: ADC
6/19/2026
Explore how our integrated bioconjugation platform and expanded capabilities can help advance the development and scalable manufacturing of next-generation therapeutics.
-
Lonza Advanced Synthesis Capabilities Update June 2026: ADC
6/19/2026
Uncover how integrated late-phase bioconjugate capabilities and scalable manufacturing strategies are helping to address the challenges of emerging modalities as they progress toward commercial production.
-
Curia Capabilities Update June 2026: Microbial Development & Manufacturing
6/19/2026
Whether you're developing a new molecule or optimizing an existing process, this session will offer practical insights into overcoming scale-up challenges and accelerating manufacturing readiness.
-
From Curiosity To Cure: The Evolution Of Curia Spain
6/19/2026
Discover how Curia Spain grew from a small local consultancy into a global pharmaceutical and biotechnology leader, delivering innovative APIs, biologics, and manufacturing solutions that improve lives around the world.
-
Simtra BioPharma Solutions June 2026 Capabilities Update: ADC
6/19/2026
Coordinate expertise across development, manufacturing, and testing to streamline ADC workflows, cut handoffs, and accelerate timelines — moving teams from early development to commercialization.
-
Avid Bioservices Capabilities Update June 2026: Cell Line Development
6/19/2026
Explore how integrated cell line development and early-stage capabilities enable faster timelines while building a strong foundation for clinical and commercial success.
-
IDT Biologika June 2026 Capabilities Update: Microbial Development & Mfg
6/19/2026
Explore how advanced microbial platforms and integrated manufacturing enable scalable biopharma production, speeding development and ensuring consistent, high-quality output.
-
FUJIFILM Biotechnologies June 2026 Capabilities Update: Microbial Development & Mfg
6/19/2026
Explore FUJIFILM Biotechnologies’ process development capabilities that make reaching IND quickly a reality, while our experts work with you to create flexible approaches to BLA.
-
WuXi Biologics Capabilities Update June 2026: Cell Line Development
6/19/2026
Targeted integration improves titer, stability, and consistency in cell line development, accelerating timelines, reducing risk, and enabling scalable, data-driven CMC for complex biologics.